Data / Research funding / Tennessee / East Tennessee State University
East Tennessee State University: 45 NIH awards ($30.6M) and 3 NSF awards ($969.9K), fiscal years 2021 to 2026
East Tennessee State University in Johnson City, TN is funded under 45 NIH awards ($30.6M) and 3 NSF awards ($969.9K) in the NIH and NSF award files, read 2026-11-03. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- V5LLVC627U34
- State
- Tennessee
Awards
48 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Training Innate Immunity: A new approach to the treatment of Sepsis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $2,271,692 | April 1, 2016 | May 31, 2026 | WILLIAMS, DAVID L. | reporter.nih.gov |
| Studies to Advance Recovery Supports (STARS) in Central Appalachia | NIH | National Institute on Drug Abuse | 2021 to 2024 | $2,041,100 | July 15, 2020 | April 30, 2026 | PACK, ROBERT P | reporter.nih.gov |
| Afferent Mechanisms of Vagal Neuromodulation Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,015,543 | August 1, 2018 | April 30, 2028 | BEAUMONT, ERIC | reporter.nih.gov |
| Targeting CNTF to increase adult forebrain neurogenesis | NIH | National Institute on Aging | 2021 to 2024 | $1,714,680 | September 1, 2007 | April 30, 2026 | HAGG, THEO | reporter.nih.gov |
| Novel Role of Lactate for Cardiovascular Dysfunction in Sepsis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,645,677 | July 1, 2020 | April 30, 2026 | LI, CHUANFU | reporter.nih.gov |
| Improving olfactory neuroplasticity through FAK/CNTF signaling | NIH | National Institute on Deafness and Other Communication Disorders | 2022 to 2025 | $1,484,808 | July 1, 2022 | May 31, 2027 | JIA, CUIHONG | reporter.nih.gov |
| Complement-mediated anti-pneumococcal functions of C-reactive protein | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,480,000 | February 5, 2020 | January 31, 2026 | SINGH, SANJAY KUMAR | reporter.nih.gov |
| Novel Role of Lactate in Sepsis Impaired Immune Function | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,135,360 | December 12, 2023 | October 31, 2028 | LI, CHUANFU | reporter.nih.gov |
| S100A9 and MDSC development in sepsis. | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,110,000 | April 1, 2019 | March 31, 2026 | ELGAZZAR, MOHAMED A. | reporter.nih.gov |
| Role of Toll-Like Receptor Signaling in Cardiac Ischemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,064,452 | July 1, 2003 | February 28, 2025 | LI, CHUANFU | reporter.nih.gov |
| Novel role of LSECs in hepatic immune and metabolic function during sepsis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $941,518 | April 15, 2024 | February 28, 2029 | WANG, XIAOHUI | reporter.nih.gov |
| Mitochondrial Dysfunction in Aging CD4 T cells in HIV-immune Non-responders. | NIH | National Institute on Aging | 2021 to 2023 | $802,618 | September 5, 2021 | August 31, 2025 | YAO, ZHI Q. | reporter.nih.gov |
| A novel CRISPR/Cas12 system targeting HBV DNA for gene therapy | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $725,466 | November 1, 2024 | February 28, 2025 | YAO, ZHI Q. | reporter.nih.gov |
| Mechanism of telomere attrition and premature T cell aging during HCV infection | NIH | National Institute on Aging | 2022 to 2023 | $704,290 | March 1, 2022 | February 28, 2025 | ZHAO, JUAN | reporter.nih.gov |
| The Role of Histone Deacetylases in Age-related Macular Degeneration | NIH | National Eye Institute | 2021 to 2022 | $703,127 | April 1, 2018 | September 30, 2023 | KLEINMAN, MARK E | reporter.nih.gov |
| Enhancing chemotherapeutic efficacy in triple-negative breast cancer via DSTYK silence | NIH | National Cancer Institute | 2023 to 2024 | $681,189 | April 10, 2023 | January 16, 2025 | JIANG, YONG | reporter.nih.gov |
| Targeting blood-derived integrin signaling after stroke | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $647,500 | July 15, 2018 | April 30, 2024 | HAGG, THEO | reporter.nih.gov |
| Transcriptional Activation of p62 by the master antioxidant NRF2 in EBV latency | NIH | National Cancer Institute | 2021 to 2023 | $521,828 | August 1, 2023 | July 31, 2024 | WANG, LING | reporter.nih.gov |
| Histone Expression in the Aging RPE | NIH | National Eye Institute | 2025 | $521,572 | January 1, 2025 | December 31, 2029 | KLEINMAN, MARK E | reporter.nih.gov |
| Hypocretin contributions to compulsive methamphetamine self-administration in rats | NIH | National Institute on Drug Abuse | 2021 to 2022 | $497,859 | April 1, 2017 | July 31, 2024 | SCHMEICHEL, BROOKE E | reporter.nih.gov |
| The Role of Neuro-Immune Synapse in Macrophage Migration | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $484,475 | May 15, 2022 | January 31, 2025 | YAKUBENKO, VALENTIN P | reporter.nih.gov |
| Request for the Acquisition of a Vevo F2 Ultrasound Imaging System | NIH | Office of the Director, National Institutes of Health | 2025 | $481,800 | May 1, 2025 | April 30, 2026 | WANG, XIAOHUI | reporter.nih.gov |
| Modulating the pharmacodynamics of methamphetamine and fentanyl co-use via hypocretin pathways | NIH | National Institute on Drug Abuse | 2025 | $457,701 | August 1, 2025 | April 30, 2030 | SCHMEICHEL, BROOKE E | reporter.nih.gov |
| Targeting the Oncogenic Transcription Factor IRF4 in Hematological Malignancies | NIH | National Institute of Dental & Craniofacial Research | 2021 | $447,000 | June 1, 2021 | May 31, 2024 | NING, SHUNBIN | reporter.nih.gov |
| Gender-specific Role of ATM in the Heart | NIH | National Heart, Lung, and Blood Institute | 2021 | $423,196 | June 20, 2021 | May 31, 2025 | SINGH, KRISHNA | reporter.nih.gov |
| Dual specific gene editing drugs delivered by nanoparticles targeting HBV/HIV coinfection | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $419,845 | May 10, 2021 | April 30, 2024 | YAO, ZHI Q. | reporter.nih.gov |
| PFAS, Renal Hemodynamics, and Kidney Disease | NIH | National Institute of Environmental Health Sciences | 2025 | $416,750 | September 23, 2025 | September 22, 2027 | POLICHNOWSKI, AARON JAMES | reporter.nih.gov |
| Glucan glycomimetics: A new approach to stimulating innate immune training | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $415,250 | June 18, 2024 | April 30, 2027 | WILLIAMS, DAVID L. | reporter.nih.gov |
| Development of an alpha-1 phosphate mannan vaccine against the emerging fungal pathogen Candida auris. | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $412,500 | September 1, 2023 | August 31, 2025 | WILLIAMS, DAVID L. | reporter.nih.gov |
| Role of endothelial cell senescence in age-related cardiomyopathy | NIH | National Institute on Aging | 2023 to 2024 | $412,500 | September 1, 2023 | July 31, 2025 | WANG, XIAOHUI | reporter.nih.gov |
| Sexually dimorphic CNTF/Ucn3 mechanism in fear extinction | NIH | National Institute of Mental Health | 2023 | $412,500 | August 1, 2023 | July 31, 2025 | JIA, CUIHONG | reporter.nih.gov |
| Genetic Characterization of phosphomannan biosynthesis in C. auris | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2022 | $407,000 | March 12, 2021 | February 29, 2024 | KRUPPA, MICHAEL D | reporter.nih.gov |
| Collaborative Research: RUI: Extraordinary circadian clocks in araneoid spiders: an integrative approach to understanding their evolutionary origins and underlying mechanisms | NSF | Evolutionary Patterns & Processes | 2023 | $403,551 | June 1, 2023 | May 31, 2027 | Darrell J Moore | nsf.gov |
| Engineering exosomes for new gRNA/Cas therapeutics to eliminate HBV infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $398,829 | January 1, 2024 | June 7, 2026 | YAO, ZHI Q. | reporter.nih.gov |
| Innate Immunity and Cardiovascular Function in Sepsis | NIH | National Institute of General Medical Sciences | 2021 | $333,000 | August 1, 2009 | May 31, 2024 | LI, CHUANFU | reporter.nih.gov |
| Development of SiPM-based spectrometers for the UCNtau and UCNA+ experiments | NSF | Physics Section | 2022 | $320,578 | July 15, 2022 | June 30, 2026 | Robert W Pattie | nsf.gov |
| Translational assessment of an FAK inhibitor for acute cerebroprotection | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $301,756 | April 15, 2023 | March 31, 2024 | HAGG, THEO | reporter.nih.gov |
| Cellular and Molecular Mechanisms of Fungal Sepsis in the Critically Ill Patient | NIH | National Institute of General Medical Sciences | 2021 | $288,600 | August 15, 2017 | April 30, 2023 | OZMENT, TAMMY REGENA | reporter.nih.gov |
| Characterization of Neutrophil Decision making during Swarming to Fungal Pathogens | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $268,848 | August 11, 2023 | July 31, 2025 | HOPKE, ALEX | reporter.nih.gov |
| Nucleus reuniens of the thalamus as a target for driving network-wide memory states | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $249,000 | July 1, 2023 | June 30, 2028 | VIENA, TATIANA DANELA | reporter.nih.gov |
| Characterization of acetaldehyde-protein adducts in alcohol-associated liver disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2025 | $249,000 | September 23, 2025 | August 31, 2028 | MACKOWIAK, BRYAN R. | reporter.nih.gov |
| Investigating Fundamental Symmetries with Ultracold Neutrons at East Tennessee State University | NSF | Physics Section | 2025 | $245,732 | September 1, 2025 | August 31, 2028 | Robert W Pattie | nsf.gov |
| Characterization of MET alteration using glioblastoma patient-derived xenograft models | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $142,691 | July 15, 2021 | June 30, 2024 | XIE, QIAN | reporter.nih.gov |
| Investigating anti-neuroinflammatory therapeutics for polysubstance use disorders | NIH | National Institute of General Medical Sciences | 2025 | $142,100 | September 1, 2025 | August 31, 2029 | SCHMEICHEL, BROOKE E | reporter.nih.gov |
| PA1627: a new regulator of the Type III secretion system | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $135,099 | May 31, 2024 | March 31, 2027 | PRITCHETT, CHRISTOPHER L. | reporter.nih.gov |
| Chemogenetic stimulation of sympathetic preganglionic neurons and serotonergic reorganization after spinal cord injury | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $75,542 | August 1, 2025 | July 31, 2027 | ZAHNER, MATTHEW RALPH | reporter.nih.gov |
| The role of cardiac mitochondrial energetics in cardiac arrhythmias and SUDEP | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $58,969 | July 1, 2021 | June 30, 2023 | FRASIER, CHAD | reporter.nih.gov |
| Analysis of modulation of the metabotropic glutamate receptor type 5 in a novel heritable model of drug abuse vulnerability | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $39,070 | July 1, 2023 | May 4, 2024 | PEETERS, LOREN D | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 16 | $5,525,502 | 1 | $245,732 |
| 2024 | 17 | $5,636,376 | 1 | $103,476 |
| 2023 | 17 | $5,707,399 | 2 | $511,070 |
| 2022 | 16 | $5,898,646 | 1 | $109,583 |
| 2021 | 21 | $7,815,377 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 10 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.855 | January 7, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed) | RFA-AI-28-024 | NIH | 93.855 | February 11, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed) | RFA-LM-28-001 | NIH | 93.855 | February 11, 2027 | $775,000 | Same assistance listing 93.855 as 10 awards here |
| NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) | PA-27-100 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional) | PA-27-102 | NIH | 93.855 | April 5, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed) | PA-24-176 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed) | PA-24-185 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) | PA-24-187 | NIH | 93.855 | May 7, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
Topics of its NIH awards
- Infectious Diseases
- Genetics
- Neurosciences
- Biotechnology
- Brain Disorders
- Hematology
- Cardiovascular
- Aging
- Heart Disease
- Sepsis
- Chronic Liver Disease and Cirrhosis
- Digestive Diseases
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.